Global Aortic Valve Replacement Devices Patent Landscape Report 2024

Global Aortic Valve Replacement Devices Market Size

The global aortic valve replacement devices market was valued at USD 7.42 billion in 2023. It is expected to grow at a CAGR of 10.1% during the forecast period of 2024-2032 and attain a market value of USD 17.67 billion by 2032.

The market growth is driven by the rising prevalence of cardiovascular diseases and aging population across the globe. Patents are focused on advanced technologies such as transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SUAVR) among aortic valve replacement devices.

Patent Landscape Report Coverage

The Global Aortic Valve Replacement Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for aortic valve replacement devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with aortic valve replacement devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within aortic valve replacement device technologies.

Key Inclusions

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for aortic valve replacement device technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with aortic valve replacement devices.

Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for aortic valve replacement devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for aortic valve replacement devices and their relative value in the IP are covered in the final report.

Aortic Valve Replacement Devices Patent Outlook

As the world's population ages, conditions related to valves, such as aortic stenosis, are becoming more common. An increased risk of heart conditions requiring valve replacement is seen in older adults. As a result, the need for AVR devices is rising because of this demographic change.

Patent applications are related to advancements in aortic valve replacement (AVR) technology, like transcatheter aortic valve replacement (TAVR) and minimally invasive procedures. These developments spur market expansion by making AVR procedures more approachable to patients.

The rising need for aortic valve replacements is partly caused by the rising prevalence of cardiovascular diseases brought on by factors such as obesity and changes in lifestyle. This also impacts the number of patent applications as the demand for efficient AVR devices increases with more people experiencing heart valve problems.

What are Aortic Valve Replacement Devices?

Aortic valve replacement devices are used to replace a malfunctioning or damaged aortic valve in the heart. These devices, which can be bioprosthetic or mechanical, help the body's circulation return to normal. They are essential for the treatment of diseases related to the valves, such as aortic stenosis.

The components of aortic valve replacement devices include transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SUAVR). Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that involves inserting a new valve via a catheter to replace an ailing aortic valve. A small incision is made to implant the new valve, frequently obviating the need for open heart surgery. For patients at high risk or ineligible for conventional surgery, TAVR is advantageous as it provides a quicker recovery with fewer procedural risks.

Aortic Valve Replacement Devices Industry Growth Drivers

Technological Advancements is Expected to Boost the Patent Industry Growth

Improvements in AVR device technology, such as the creation of less invasive procedures and better device designs, greatly improve patient outcomes and increase available treatment options. By enabling valve replacements through a catheter and eliminating the need for open heart surgery, innovations like transcatheter aortic valve replacement (TAVR) have completely changed the field.

For instance, Edward’s SAPIEN X4 TAVR System with improved delivery systems and sophisticated imaging capabilities enables more accurate valve placement and lowers procedural risks. This technological advance demonstrates how improvements in procedural outcomes and the expansion of the patient base are eligible for the procedure. This drives market growth and contributes to the growing adoption of TAVR. Patents covering these technologies are crucial for companies and thus impact the aortic valve replacement device patent landscape. There has been a significant increase in patent activity which focuses on enhancing the performance of aortic valve replacement devices. There were 4 patents granted in 2022 which increased to 24 patent grants in 2023.

Rising Cardiovascular Diseases is Expected to Propel Aortic Valve Replacement Devices Patent Industry

AVR devices are in higher demand because of the rising prevalence of cardiovascular diseases like aortic stenosis and other heart valve disorders. The prevalence of these conditions is fueled by factors like poor diets, sedentary lifestyles, and rising obesity rates, which highlights the need for efficient valve replacement treatments. This also impacts the frequency of patent applications as the requirement for efficient devices it witnessing a surge with more people experiencing heart valve problems.

Aortic Valve Replacement Devices Patent Segmentation

The report will cover the following sections in detail

Analysis by Product Type

• Transcatheter Aortic Valve Replacement (TAVR)

• Sutureless Aortic Valve Replacement (SUAVR)

• Others

Analysis by Surgery Type

• Open Surgery

• Minimally Invasive Surgery

Aortic Valve Replacement Devices Patent Segmentation Analysis

The breakup based on product type includes transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SUAVR). Sutureless aortic valve replacement (SUAVR) is a method that does not need sutures, making the replacement of an aortic valve easier. Instead, a self-expanding or balloon-expandable mechanism is used to anchor the valve in place, which shortens the procedure and enhances patient outcomes. Patients with complex anatomy or those who are at high risk for traditional surgical techniques will benefit most from this approach.

Detailed technological data will be provided for all specified segments classified in this report.

Aortic Valve Replacement Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for aortic valve replacement device patents, having around 300+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contribute to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with aortic valve replacement devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Medtronic Inc

This company was founded in 1949, with its main office located in Dublin, Ireland. The company is well-known for its advancements in minimally invasive procedures for the treatment of aortic stenosis, such as the HawkValve and CoreValve systems, which are aortic valve replacement devices. The improvements in procedure efficiency and patient outcomes are the main goals of Medtronic's advancements in this field.

Pacesetter Inc

The company was founded in 1986, with its main office located in Sylmar, California. This company was a pioneer in the field of aortic valve replacement and cardiac rhythm management. It created cutting-edge heart condition management technologies, such as sophisticated aortic valve replacement systems.

Other companies include Edwards Lifesciences Corp, Boston Scient Scimed Inc., Human Genome Sciences Inc., 3dt Holdings LLC, Corvia Medical Inc., Koninklijke Philips NV, Tempus Labs Inc., Electro Cat LLC, Stenomics Inc., Volcano Corp, and Abps Venture One LTD, among others.

Reasons to Purchase this Report

The Aortic Valve Replacement Devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of aortic valve replacement devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in aortic valve replacement devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the aortic valve replacement devices patent landscape.

• Risk Assessment: In technology-intensive fields such as aortic valve replacement devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Aortic Valve Replacement Devices Patent Landscape Report

• Who are the key players in the aortic valve replacement devices patent landscape?

• How is the patent portfolio distributed geographically?

• What are the emerging trends in aortic valve replacement device patents?

• How has the patent landscape evolved over time?

• What are the strategic insights for market players and investors?

• What is the technological focus of patents in the aortic valve replacement devices industry?

• How do patent strategies impact competitive advantage?

• What are the implications of patent filings in aortic valve replacement devices?

• What are the challenges and opportunities in the aortic valve replacement devices patent landscape?

• What are the regulatory and legal considerations?

• What technological innovations have recently emerged in aortic valve replacement devices?

Related Reports:

Global Aortic Stent Graft Market

Global Heart Valve Devices Market

Global Transcatheter Pulmonary Valve Market